XML 54 R43.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Apr. 10, 2019
Mar. 15, 2019
Dec. 31, 2017
Sep. 26, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Sale of Stock, Number of Shares Issued in Transaction 700,000 7,300,000    
Gross proceeds from registered sale equity securities $ 8.8      
Shares Issued, Price Per Share   $ 1.10    
Underwriting discounts and offering expenses from sale of equity $ 0.7      
Percentage of common stock outstanding 0.80% 8.90%    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period       628,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount       $ 0.6
Unrecognized compensation weighted average period       two years.
Employment Agreement [Member] | Dr. John Fan [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
[custom:GrantExpirationDate]     Dec. 31, 2020  
Total fair value awards     $ 1.7  
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $5.25 [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     640,000  
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $6.00 [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     150,000  
Employment Agreement [Member] | Dr. John Fan [Member] | Price Equal to or Greater Than $7.00 [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     150,000